185 related articles for article (PubMed ID: 27476724)
1. Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.
Shi J; Zhou W; Zhu B; Hyland PL; Bennett H; Xiao Y; Zhang X; Burke LS; Song L; Hsu CH; Yan C; Chen Q; Meerzaman D; Dagnall CL; Burdette L; Hicks B; Freedman ND; Chanock SJ; Yeager M; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2016 Dec; 136(12):2436-2443. PubMed ID: 27476724
[TBL] [Abstract][Full Text] [Related]
2. Role of rare germline copy number variation in melanoma-prone patients.
Fidalgo F; Rodrigues TC; Silva AG; Facure L; de Sá BC; Duprat JP; Achatz MI; Rosenberg C; Carraro DM; Krepischi AC
Future Oncol; 2016 Jun; 12(11):1345-57. PubMed ID: 27020340
[TBL] [Abstract][Full Text] [Related]
3. E2F1 germline copy number variations and melanoma susceptibility.
Rocca MS; Benna C; Mocellin S; Rossi CR; Msaki A; Di Nisio A; Opocher G; Foresta C
J Transl Med; 2019 May; 17(1):181. PubMed ID: 31142321
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
6. Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.
Vignoli M; Scaini MC; Ghiorzo P; Sestini R; Bruno W; Menin C; Gensini F; Piazzini M; Testori A; Manoukian S; Orlando C; D'Andrea E; Bianchi-Scarrà G; Genuardi M
Melanoma Res; 2008 Dec; 18(6):431-7. PubMed ID: 19011513
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
[TBL] [Abstract][Full Text] [Related]
8. Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family.
Yang XR; Brown K; Landi MT; Ghiorzo P; Badenas C; Xu M; Hayward NK; Calista D; Landi G; Bruno W; Bianchi-Scarrà G; Aguilera P; Puig S; Goldstein AM; Tucker MA
Pigment Cell Melanoma Res; 2012 Mar; 25(2):243-7. PubMed ID: 22225770
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
12. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B
Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
15. Copy number variations and susceptibility to lateral temporal epilepsy: a study of 21 pedigrees.
Fanciulli M; Pasini E; Malacrida S; Striano P; Striano S; Michelucci R; Ottman R; Nobile C
Epilepsia; 2014 Oct; 55(10):1651-8. PubMed ID: 25243798
[TBL] [Abstract][Full Text] [Related]
16. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
18. Association of melanoma with intraepithelial neoplasia of the pancreas in three patients.
Fidalgo F; Gomes EE; Moredo Facure L; Da Silva FC; Carraro DM; de Sá BC; Duprat Neto JP; Krepischi AC
Exp Mol Pathol; 2014 Aug; 97(1):144-7. PubMed ID: 24984283
[TBL] [Abstract][Full Text] [Related]
19. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]